Long-term Efficacy and Safety of Risperidone in Patients with Schizophrenia / 대한정신약물학회지
Korean Journal of Psychopharmacology
; : 58-69, 2003.
Article
em Ko
| WPRIM
| ID: wpr-23243
Biblioteca responsável:
WPRO
ABSTRACT
Most informations on the efficacy and safety of new antipsychotic durgs are based on short-term clinical trials. Short-term studies are usually conducted as well-controlled, randomized, comparative studies. However, they do not provide any informations about delayed efficacy or late-onset adverse events such as tardive dyskinesia, functional recovery, relapse or recur rates and maintenance treatment. This is why there is growing interest in long-term clinical studies of antipsychotic drugs. The number of well designed long-term studies, however, are limited compared to that of short-term studies because of practical reasons as well as some methodological issues. In this article, the authors reviewed original research papers on the long-term treatment outcomes of risperidone while discussing the methodological considerations.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Recidiva
/
Esquizofrenia
/
Antipsicóticos
/
Risperidona
/
Transtornos dos Movimentos
Tipo de estudo:
Clinical_trials
Limite:
Humans
Idioma:
Ko
Revista:
Korean Journal of Psychopharmacology
Ano de publicação:
2003
Tipo de documento:
Article